Articles for Covishield

Supreme Court Says Centre Can Respond To Plea Seeking Direction To Specify Side Effects Of Covishield Vaccine
1 week, 5 days ago

Supreme Court Says Centre Can Respond To Plea Seeking Direction To Specify Side Effects Of Covishield Vaccine

Live Law  

The Supreme Court on December 10 said the Union Government may file its response to an amendment application seeking that possible adverse effects of Oxford–AstraZeneca's Covishield should be specified in the vaccines including the treatment for those effects. Opposing this, Additional Solicitor General Aishwarya Bhati responded: "Mylords looked into the entire issue of COVID vaccination, which was disposed of by …

Writ Issue Covid Effects Vaccine Court Order Petitioners
The right way to counter a poor Covaxin safety study
4 months, 3 weeks ago

The right way to counter a poor Covaxin safety study

The Hindu  

It took all of five days for the Indian Council of Medical Research to strongly criticise the poor design of the long-term safety study of Covaxin by researchers from the Banaras Hindu University, Varanasi. A publication failure that is glaring Three years after the interim data were posted as a preprint, Bharat Biotech and ICMR are yet to publish any …

Trial Study Vaccine Participants Clinical Icmr Bhu
Covishield Side Effects: Doctors' Group Urges Govt to Review All Covid Vaccines
7 months, 1 week ago

Covishield Side Effects: Doctors' Group Urges Govt to Review All Covid Vaccines

News 18  

In the wake of pharmaceutical giant AstraZeneca admitting in a UK court that its Covid vaccine can cause blood clots in rare cases, a group of doctors on Thursday expressed deep concern over the safety of the Covishield vaccine manufactured by the Serum Institute of India. At a press conference, the doctors, under the banner of the Awaken India Movement, …

India Covid Vaccines Covishield Vaccine
‘We need to stop the fear mongering on vaccines’
7 months, 2 weeks ago

‘We need to stop the fear mongering on vaccines’

The Hindu  

The COVID-19 pandemic has exacerbated a fringe anti-vaccine movement, previously limited to niche communities, either sceptical about vaccine benefits, or suspicious of vaccination motives. The trigger for this was a court submission by Astra Zeneca that its COVID-19 vaccine, ChAdOx1-nCoV19, manufactured as Covishield by Serum Institute in India, can in rare cases cause clots due to TTS. While we do …

Health India Europe Indian Heart Risk Vaccines
AstraZeneca withdraws Covishield pointing to low demand, but did rare side effects also play a role?
7 months, 2 weeks ago

AstraZeneca withdraws Covishield pointing to low demand, but did rare side effects also play a role?

The Hindu  

Published : May 09, 2024 13:21 IST - 3 MINS READ The pharmaceutical giant AstraZeneca has reportedly withdrawn its COVID-19 vaccine Vaxzevria, also known as Covishield, worldwide, citing commercial reasons for the decision. Vaxzevria saved millions of lives AstraZeneca, who developed the vaccine with Oxford University, said it was “incredibly proud of the role Vaxzevria played in ending the global …

Vaccine Oxford Variant Astrazeneca Ema Side Effects Tts
AstraZeneca's Covishield Showed Lowest Incidence of Side Effects in India Versus Globally, Says Top Govt Official
7 months, 2 weeks ago

AstraZeneca's Covishield Showed Lowest Incidence of Side Effects in India Versus Globally, Says Top Govt Official

News 18  

AstraZeneca’s vaccine has demonstrated the lowest incidence of side effects in India compared to the global average, a top government official involved in the national roll-out of Covid-19 vaccination told News18. “But only around 50 cases witnessed Thrombosis with Thrombocytopenia Syndrome — a rare side effect caused by the jab — of the 180 crore doses administered against 4 to …

India Official Effects Vaccine Side Effects Covishield Tts
After AstraZeneca covid-19 vax recall worldwide, Serum says it stopped manufacturing jabs in Dec 2021
7 months, 2 weeks ago

After AstraZeneca covid-19 vax recall worldwide, Serum says it stopped manufacturing jabs in Dec 2021

Live Mint  

New Delhi: The Serum Institute of India on Wednesday said it has stopped making and supplying covid-19 vaccine Covishield after AstraZeneca, the British drugmaker that helped develop the vaccine, announced it too was withdrawing its version of the jab worldwide. The development follows the launch of a class action suit in the UK over allegations that the UK vaccine caused …

India Vaccines Vaccine Astrazeneca Covishield Sii Stopped Manufacturing
Stopped manufacturing Covishield since December 2021, says Serum Institute
7 months, 2 weeks ago

Stopped manufacturing Covishield since December 2021, says Serum Institute

Hindustan Times  

Pune-based Serum Institute of India stopped manufacturing its anti-Covid-19 vaccine Covishield in 2021, according to a statement issued by the company on Wednesday after British-Swedish pharmaceutical manufacturer AstraZeneca announced it was withdrawing its vaccine against Covid, Vaxzevria, due to “commercial reasons” as demand for it decreased globally. Consequently, since December 2021, we have stopped the manufacturing and supply of additional …

India Vaccines Syndrome Ema 2021 Serum Institute Of India Serum Institute
As AstraZeneca announces vaccine withdrawal, Serum Institute says stopped Covishield in 2021
7 months, 2 weeks ago

As AstraZeneca announces vaccine withdrawal, Serum Institute says stopped Covishield in 2021

New Indian Express  

NEW DELHI: Days after AstraZeneca admitted for the first time in court documents that their Covid-19 vaccine can cause a rare and dangerous side effect, the British pharma giant announced that they are withdrawing it globally. In its statement, AstraZeneca said, "As multiple, variant COVID-19 vaccines have since been developed, there is a surplus of available updated vaccines. According to …

India Vaccine Serum Institute Covishield
COVID-19 vaccines: Much ado about known unknowns
7 months, 2 weeks ago

COVID-19 vaccines: Much ado about known unknowns

The Hindu  

There are things we know that we don’t know. This risk was identified and flagged back in 2021; packaging was modified to insert information associated with the side effects; even the WHO wrote about it first in May 2021 and then in 2023.Read Bindu Shajan Perapaddan’s report on the rare vaccine side-effect is “no secret” and they are “well aware …

Health Food India Court Risk Covid Vaccine
Karnataka Health Department serves notice to private law college for spreading false rumours about Covishield vaccine
7 months, 2 weeks ago

Karnataka Health Department serves notice to private law college for spreading false rumours about Covishield vaccine

The Hindu  

The Department of Health and Family Welfare has served a notice to Sri Siddaramaiah Law College, Chickballapur, for allegedly spreading false rumours that people who have been vaccinated with Covishield vaccine suffer from cardiac arrests. The college allegedly claimed that the Health Department said that blood clots and sudden heart attacks are causing deaths as a result of Covishield vaccination …

Covishield Covishield Vaccine False Rumours
Covishield vaccine has had more benefits than risks, says study by Kozhikode doctors
7 months, 2 weeks ago

Covishield vaccine has had more benefits than risks, says study by Kozhikode doctors

The Hindu  

At a time when the safety aspects of the Covishield vaccine have kicked up a row, a retrospective study by two doctors from Kozhikode has claimed that its risks are minimal in view of the benefits. The controversy arose after pharmaceutical company AstraZeneca admitted in the High Court of London, United Kingdom, that its vaccine against COVID-19 had the potential …

India Vaccine Kozhikode Reactions Adverse Covishield
PM Modi's photo removed from vaccine certificates amidst Covishield controversy
7 months, 3 weeks ago

PM Modi's photo removed from vaccine certificates amidst Covishield controversy

Deccan Chronicle  

New Delhi: Amidst the ongoing controversy surrounding the Covishield vaccine, Prime Minister Narendra Modi's photograph has been removed from Covid-19 vaccine certificates. While speculation arose linking this action to AstraZeneca's acknowledgment of rare blood clotting cases associated with the vaccine, official sources have attributed it to the implementation of the election model code of conduct. The court had dismissed a …

India Vaccine Covishield
Covishield: Gujarat Cong Demands Compensation, BJP Claims Heart Attacks Not Linked to Vaccine
7 months, 3 weeks ago

Covishield: Gujarat Cong Demands Compensation, BJP Claims Heart Attacks Not Linked to Vaccine

News 18  

The opposition Congress on Wednesday alleged that the BJP government at the centre did not follow the guidelines of the World Health Organisation, and demanded that the relatives of those who died due to heart attack or similar reasons after taking the Covishield vaccine against coronavirus should be paid compensation. Doctors associated with the Gujarat BJP, however, said a study …

India Congress Vaccines Bjp Vaccine Heart Attack Gohil
Covishield | Plea in Supreme Court for probe panel for vaccine’s ‘risk factors’
7 months, 3 weeks ago

Covishield | Plea in Supreme Court for probe panel for vaccine’s ‘risk factors’

The Hindu  

The controversy over the safety aspects of the Covishield vaccine reached the Supreme Court on Wednesday, May 1, 2024, with a petition seeking the constitution of an expert medical panel to study the risk factors. Now after the document filed in UK court by the developer of Covishield, we are compelled to think on the risk and hazardous consequences of …

India Supreme Court Blood Clots Vaccine Covishield
Only 7 Out 10 Lakh May Face Clotting Risk Due to Covishield: Former ICMR Scientist
7 months, 3 weeks ago

Only 7 Out 10 Lakh May Face Clotting Risk Due to Covishield: Former ICMR Scientist

News 18  

Only seven to eight individuals out of 10 lakh, who receive the coronavirus vaccine Covishield, face the risk of experiencing a rare side effect known as thrombosis thrombocytopenia syndrome. India’s top epidemiologist, former ICMR scientist Dr Raman Gangakhedkar, said those who got this vaccine have “no risk at all”. Gangakhedkar, who is known for his simplistic approach to clearing complicated …

Indian Risk Vaccine Icmr 10 Lakh Covishield Tts
AstraZeneca’s submission in U.K. court nothing new, say doctors over Covishield’s potential to cause blood clots
7 months, 3 weeks ago

AstraZeneca’s submission in U.K. court nothing new, say doctors over Covishield’s potential to cause blood clots

The Hindu  

Following pharmaceutical company AstraZeneca’s admission in U.K. court documents that its vaccine against COVID-19 has the potential to cause Thrombosis with Thrombocytopenia Syndrome, a rare side effect associated with blood clotting, doctors in India said this is not new information and that they are “well aware of the warning which has been available in India as an insert with the …

India Rare Cause Covid Heart Attacks Vaccine Effect
AstraZeneca admits its Covishield vaccine may lead to rare side effect
7 months, 3 weeks ago

AstraZeneca admits its Covishield vaccine may lead to rare side effect

New Indian Express  

As reported by The Telegraph, although AstraZeneca is disputing the allegations, it acknowledged in a legal filing submitted to the High Court in February that the vaccine "can, in very rare instances, lead to TTS." AstraZeneca, in a May 2023 response to Scott's lawyers, contested any direct link between the vaccine and TTS, stating they do not accept such a …

Vaccine Telegraph Scott Jamie
What we really need: A feminist health policy
9 months, 1 week ago

What we really need: A feminist health policy

The Hindu  

The International Day for Women is not something we ignore at the health desk. Quoting the recently- released World Economic Forum’s report, ‘Closing the Women’s Health Gap’, she underscores the profound disparity between men’s and women’s health worldwide. Selvavinayagam, Director of Public Health and Preventive Medicine, at least 50% of women covered under the ‘First 1,000 Days of Life’ initiative, …

Health Food India Policy Children Women Tamil Nadu
Covishield more effective than Covaxin: Study
9 months, 2 weeks ago

Covishield more effective than Covaxin: Study

New Indian Express  

BENGALURU: Covishield vaccine had higher antibody response compared to Covaxin during the pandemic, according to a study by a consortium of 11 institutions led by scientists from the National Centre for Biological Sciences, Bengaluru. In all, 691 people aged between 18 and 45, mostly from Bengaluru and Pune, were part of the study.’Immunogenicity of SARS - CoV-2 vaccines Covaxin and …

India Bengaluru Study Vaccine Covaxin Covishield
What study on Covishield versus Covaxin vaccine reveals
9 months, 2 weeks ago

What study on Covishield versus Covaxin vaccine reveals

The Hindu  

March 07, 2024 10:59 am | Updated March 09, 2024 10:53 am IST - Bengaluru A new study by a consortium of 11 institutes, led by scientists from the National Centre for Biological Sciences, has found that the Covishield vaccine demonstrated more robust immune responses compared to Covaxin. The key findings state that Covishield, leveraging a virus vector to deliver …

Indian Covid Study Immune Vaccine Covaxin Ncbs
Beyond the COVID-19 pandemic: Unanswered questions, lessons learnt and ongoing challenges
1 year, 2 months ago

Beyond the COVID-19 pandemic: Unanswered questions, lessons learnt and ongoing challenges

Firstpost  

The COVID-19 pandemic that impacted all aspects of human life, quite literally cancelled the planet. Was any internal advice given to the Government of India that the mRNA vaccines developed by Pfizer and Moderna were better, despite the fact that they were significantly more expensive and difficult to administer? Covishield, developed by Oxford-AstraZeneca in the UK, is similar to previous …

India Pandemic Disease Vaccines Covid Cia Bharat
The various strategies of vaccine diplomacy
1 year, 3 months ago

The various strategies of vaccine diplomacy

The Hindu  

Suzuki, Mao & Yang, Shiming, ‘Political Economy of vaccine diplomacy: Explaining varying strategies of China, India, and Russia’s COVID-19 vaccine diplomacy’, Review of International Political Economy, 30:3, 865-890. They argue that “countries with an advantage in vaccine R&D would be more open to technology transfer; countries with greater manufacturing capability would be more likely to keep vaccine production within their …

India China Diplomacy Russia Indian Production Vaccines
India-made mRNA vaccine priced at ₹2,292, will be available as a booster dose
1 year, 5 months ago

India-made mRNA vaccine priced at ₹2,292, will be available as a booster dose

The Hindu  

India’s first indigenously developed mRNA vaccine against the dominant Omicron variant of the COVID-19 coronavirus will cost ₹2,292, Sanjay Singh, CEO, Gennova Biopharmaceuticals, said at a press conference on June 24. The vaccine will for now only be available as a booster or “precaution dose”, that is, somebody who has already been vaccinated thrice will be ineligible as the relevant …

India Vaccines Singh Available Vaccine Mrna Booster